CLOSE
Science & Technology

by -
0 1919
Michael Jensen on a container ship in the Pacific Ocean, where he was measuring marine clouds. Photo from M. Jensen

By Daniel Dunaief

They often seem to arrive at the worst possible time, when someone has planned a picnic, a wedding or an important baseball game. In addition to turning the sky darker, convective clouds can bring heavy rains and lightning.

For scientists like Michael Jensen, a meteorologist at Brookhaven National Laboratory, these convective clouds present numerous mysteries, including one he hopes to help solve.

Aerosols, which come from natural sources like trees or from man-made contributors, like cars or energy plants, play an important role in cloud formation. The feedbacks that occur in a cloud system make it difficult to understand how changes in aerosol concentrations, sizes or composition impact the properties of the cloud.

“One of the big controversies in our field is how aerosols impact convection,” Jensen explained in an email. “A lot of people believe that when a storm ingests aerosols, it makes it stronger, because there are changes to precipitation and particles in the clouds.”

This process is called convective invigoration, which could make it rain more.

Another group of scientists, however, believes that the aerosols have a relatively small effect that is masked by other storm processes, such as vertical winds. 

Strong vertical motions that carry air, water and heat through the atmosphere are a signature of convective storms.

Jensen will lead an effort called Tracking Aerosol Convection Interactions Experiment, or TRACER, starting in April of 2021 in Houston that will measure the effect of these aerosols through a region where he expects to see hundreds of convective storm clouds in a year. 

From left, Donna Holdridge, from Argonne National Laboratory; Michael Jensen, kneeling; and Petteri Survo, from Vaisal Oyj in Helsinki, Finland during a campaign in Oklahoma to study convective storms. The team is testing new radiosondes, which are instruments sent on weather balloons. Photo from M. Jensen

The TRACER team, which includes domestic and international collaborators, will measure the clouds, precipitation, aerosol, lighting and atmospheric thermodynamics in considerable detail. The goal of the campaign is to develop a better understanding of the processes that drive convective cloud life cycle and convective-aerosol interactions.

Andrew Vogelmann, a technical co-manager of the Cloud Properties and Processes Group at BNL with Jensen, indicated in an email that the TRACER experiment is “generating a buzz within the community.” 

While other studies have looked at the impact of cities and other aerosol sources on rainfall, the TRACER experiment is different in the details it collects. In addition to collecting data on the total rainfall, researchers will track the storms in real time and will focus on strong updrafts in convection, which should provide specific information about the physics.

Jensen is exploring potential sites to collect data on the amount of water in a cloud, the size of the drops, the phase of the water and the shapes of the particles. He will use radar to provide information on the air velocities within the storm.

He hopes to monitor the differences in cloud characteristics under a variety of aerosol conditions, including those created by industrial, manufacturing and transportation activities.

Even a perfect storm, which starts in an area with few aerosols and travels directly through a region with many, couldn’t and wouldn’t create perfect data.

“In the real atmosphere, there are always complicating factors that make it difficult to isolate specific processes,” Jensen said. To determine the effect of aerosols, he is combining the observations with modeling studies.

Existing models struggle with the timing and strength of convective clouds.

Jensen performed a study in 2011 in Oklahoma that was focused on understanding convective processes, but that didn’t hone in on the aerosol-cloud interactions.

Vogelmann explained that Jensen is “well-respected within the community and is best known for his leadership” of this project, which was a “tremendous success.”

Since that study, measurement capabilities have improved, as has modeling, due to enhanced computing power. During the summer, Long Island has convective clouds that are similar to those Jensen expects to observe in Houston. Weather patterns from the Atlantic Ocean for Long Island and from the Gulf of Mexico for Houston enhance convective development.

“We experience sea breeze circulation,” Jensen said. Aerosols are also coming in from New York City, so many of the same physical processes in Houston occur on Long Island and in the New York area.

As the principal investigator, Jensen will travel to Houston for site selection. The instruments will collect data every day. During the summer, they will have an intensive operational period, where Jensen and other members of the TRACER team will forecast the convective conditions and choose the best days to add cloud tracking and extra observations.

Jensen expects the aerosol impact to be the greatest during the intermediate strength storms. 

The BNL meteorologist described his career as jumping back and forth between deep convective clouds and marine boundary layer clouds.

Jensen is a resident of Centerport and lives with his wife Jacqui a few blocks from where he grew up. Jacqui is a banker for American Community Bank in Commack. The couple has a 22-year-old son Mack, who is a substitute teacher at the Harborfields school district.

Jensen describes his family as “big music people,” adding that he plays euphonium in a few community band groups, including the North Shore Community Band of Longwood and the Riverhead Community Band.

As an undergraduate at SUNY Stony Brook, Jensen was broadly interested in science, including engineering. In flipping through a course catalog, he found a class on atmospheric science and thought he’d try it.

Taught by Robert Cess, who is now a professor emeritus at SBU, the class “hooked” him.

Jensen has been at BNL for almost 15 years. Over that time, he said the team has “more influence in the field,” as the cloud processing group has gone from six to 18 members. The researchers have “expanded our impact in the study of different cloud regimes and developed a wide network of collaborations and connections throughout the globe.”

As for his work in the TRACER study, Jensen hopes to “solve this ongoing debate, or at least provide new insights into the relative role of aerosols and dynamics.”

by -
0 2351
From left, Anne Churchland and Tatiana Engel. Photo from CSHL

By Daniel Dunaief

Movies have often used an image of a devil on one shoulder, offering advice, and an angel on another, suggesting a completely different course of action. People, however, weigh numerous factors when making even the simplest of decisions.

The process the brain uses to make decisions involves excitatory and inhibitory neurons, which are spread throughout the brain. Technology has made it possible to study thousands of these important cells on an active mouse, showing areas that are active at the same time.

Anne Churchland, an associate professor at Cold Spring Harbor Laboratory, and Tatiana Engel, an assistant professor at the same facility, are collaborating on a three-year grant from the National Institutes of Health that will study the way neurons interact to understand the patterns that lead to decisions. 

Engel said she, Churchland and another collaborator on the project, Stanford University Professor Krishna Shenoy, applied for the funding in response to a call from the NIH to develop computational methods and models for analyzing large-scale neural activity recordings from the brain.

Churchland and Shenoy will provide experimental data for the computational models Engel’s lab will develop. The data is “huge and complex,” Engel said, and researchers need new methods to understand it. “The simple techniques don’t translate to large-scale recordings,” Engel said.

Churchland and Engel jointly hired James Roach, a postdoctoral researcher who recently earned his doctorate from the University of Michigan and works in both of their labs. 

Churchland’s lab will provide data from the mouse model, while Engel’s lab brings computational expertise.

“Little is known about how these neurons are connected to behavior,” Engel said. Their research will hope to explain the role of inhibitory cells, which may have a more finely tuned function beyond keeping cells from remaining in an excited state.

The prevailing view in the field is that inhibitory neurons provide a balancing input to the network to prevent it from generating too much excitation or creating a seizure. Inhibitors are like the regulators that tap the brakes on a network that’s becoming too active.

Excitatory neurons, by contrast, are the ones that have an important job, representing the decisions individuals make.

Churchland is going to measure neural activity using a 2-photon microscope that allows her to measure the activity of about 600 neurons simultaneously. 

“This provides an incredible opportunity to analyze the data, using tools borrowed from machine learning and dynamical systems,” she explained in an email.

What Churchland’s data has helped show, however, is that the inhibitory neurons are doing more than providing a global braking signal. “They have some dedicated role in the circuit and we don’t know what that role is yet,” Engel said.

The team will build neural circuit models to help understand how the system is wired and what role each type of cell plays in various behaviors.

“We are developing computational frameworks where we can go and analyze activities of large groups of cells and, from the data, determine how individual cells contribute to the activity of the population,” Engel said.

Brains have considerable plasticity, which means that when one area of the brain isn’t functioning for whatever reason — through an injury or a temporary blockage ‒ other areas can compensate. “The whole problem is immensely complicated to figure out what a brain area is doing normally,” she explained. The picture can “completely change when there’s brain damage.”

Research is moving in the direction of understanding and manipulating large neural circuits at once, rather than a single area at a time. 

“Models can extract general principles, which still hold true even in more complex” systems Engel said. The principles include understanding how excitatory and inhibitory cells are balanced. “Models can help you figure out what works and doesn’t work.”

Roach, the current postdoctoral researcher working with Engel and Churchland, will start with modeling and then will develop experiments to test the role of inhibitory cells. He has already worked on computer programs that interpret neurological circuits and laboratory results. He is also receiving laboratory training.

At this point, Engel and Churchland are working on basic science. Engel explained that this type of research is the foundation for translation work that will lead to an improved diagnosis and treatment of neurological disorders. Basic science can, and often does, provide insights and information that help those working to understand or treat disease, she suggested.

Churchland was pleased with her collaboration with Engel.

Engel is “best known for modeling work she did studying neural mechanisms of attention,” Churchland explained in an email. “She is a great addition to Cold Spring Harbor! We work together in the same building and are trying to unravel the mysteries of how large groups of neurons in the brain work together to make decisions.”

A resident of the facilities at Cold Spring Harbor Laboratory, Engel grew up in Vologda, which is over 300 miles north of Moscow. Starting in seventh grade, she attended physics and math schools, first in her home town and then at a boarding school at the Moscow State University.

She learned to appreciate the value of science from the journals her parents subscribed to, including one for children called Kvant magazine. She solved physics problems in that magazine. “I enjoyed the articles and problems in Kvant,” she explained in an email.

As for her work, Engel suggested that there were many discoveries ahead. “It is an exciting and transformative time in neuroscience,” she said.

by -
0 2100
Third-place winners from Commack High School from left, Luke Maciejewski, Nathan Cheung, Riley Bode, Louis Vigliette and Kevin Chen. Photo from BNL
Commack and Walt Whitman high schools take home honors
Fourth-place winners from Walt Whitman High School in Huntington Station, from left, Rena Shapiro, Eliot Yoon, Matthew Kerner and Aiden Luebker. Photo from BNL

Brookhaven National Laboratory in Upton held its annual Long Island Regional High School Science Bowl on Jan. 26. Out of 20 teams from across Long Island, Levittown’s Island Trees High School took the top spot and was awarded an all-expenses-paid trip to the National Finals in Washington, D.C., scheduled for Apr. 25 to 29. 

Old Westbury’s Wheatley School took home second place; Commack High School placed third; and Walt Whitman High School in Huntington Station placed fourth.

The event was just one of the nation’s regional competitions of the 29th Annual DOE National Science Bowl (NSB). 

A series of 111 regional high school and middle school tournaments are held across the country from January through March. Teams from diverse backgrounds are each made up of four students, one alternate, and a teacher who serves as an adviser and coach. These teams face off in a fast-paced question-and-answer format where they are tested on a range of science disciplines including biology, chemistry, Earth science, physics, energy and math. The NSB draws more than 14,000 middle- and high-school competitors.

“The National Science Bowl has grown into one of the most prestigious and competitive science academic competitions in the country, challenging students to excel in the STEM fields so vital to America’s future,” said U.S. Secretary of Energy Rick Perry. “I am proud to oversee a Department that provides such a unique and empowering opportunity for our nation’s students, and I am honored to congratulate Island Trees High School for advancing to the National Finals, where they will be competing against some of the brightest science, technology and engineering students across the country.”

The top 16 high school teams and the top 16 middle school teams in the National Finals will win $1,000 for their schools’ science departments. Prizes for the top two high school teams for the 2019 NSB will be announced on a later date.

In the competition at Brookhaven Lab, participating students received a Science Bowl T-shirt and winning teams also received trophies, medals and cash awards. Prizes were courtesy of BNL’s event sponsor, Brookhaven Science Associates, the company that manages and operates the lab for DOE.

For more information, visit www.science.energy.gov

by -
0 2780
Markus Seeliger with a model of a protein kinase. Photo from SBU

By Daniel Dunaief

They are like couples looking for each other on a dating website. Each side could theoretically find a range of connections. The focus in this dating game, however, has heavily favored understanding the preferences of one side. 

Markus Seeliger, an associate professor in the Department of Pharmacological Sciences at the Stony Brook University Renaissance School of Medicine, has taken important steps to change that, albeit in a completely different area. Instead of working with two people who are searching for a date, Seeliger studies the interactions among protein kinases, which are like switches that turn on or off cellular signals, and inhibitors, which researchers and drug companies are creating to slow down or stop the progression of diseases.

Markus Seliger

Most scientists have looked at the pairing of these molecules and protein kinases from the perspective of the inhibitor, trying to figure out if it would bind to one of the 500 protein kinases in the human body.

Seeliger, however, is exploring the coupling from the other side, looking at the selectivity of the kinases. He published recent research in the journal Cell Chemical Biology.

“People have only ever looked at the specificity from the point of view of an inhibitor,” Seeliger said. “We’ve turned it around. We’re looking at it from the perspective of kinases,” adding that kinases have been important drug targets for decades.

In an email, Michael Frohman, a SUNY distinguished professor and the chair of the Department of Pharmacological Sciences, applauded Seeliger’s efforts and said his research “is representative of the innovative work going on in many of the labs here.” 

On a first level, Seeliger discovered eight kinases that bind to a range of potential inhibitors, while the others are more selective.

Within the smaller group that binds a range of inhibitors, there was no sequence relationship between the base pairs that formed the kinases. The kinases are also not closely related in the cellular functions they regulate. They all trigger similar signaling cascades. 

Seeliger wanted to know why these eight kinases were four to five times more likely to couple with an introduced inhibitor than their more selective kinase counterparts. The Stony Brook scientist performed a three-dimensional analysis of the structure of one of these kinases at Brookhaven National Laboratory.

“They have a very large binding pocket that can accommodate many different inhibitors,” Seeliger said. Indeed, he discovered this higher level of receptivity by separating out this group of eight, which also had more flexible binding sites. If the match between the configuration of the inhibitor and the kinase isn’t perfect, the kinase can still find a way to allow the molecule to connect.

For any potential inhibitor introduced into the human body, this more flexible and accommodating group of kinases could cause unintended side effects regardless of the level of specificity between the inhibitor or drug and other targets. This could have health implications down the road, as other researchers may use the properties of these kinases to switch off programs cancer or other diseases use to continue on their destructive paths.

“Studies point to the roles of protein kinases as driving (to at least allowing and permitting) cancer growth and development,” Yusuf Hannun, the director of the Stony Brook University Cancer Center, explained in an email. “Therefore, one needs to inhibit them.”

Hannun described Seeliger as “very rigorous” and suggested he was an “up and coming scientist” whose “novel approach” shed significant new light on protein kinases.

In his research, Seeliger’s next step is to look at the existing database to see what other groups of kinases he finds and then determine why or how these switches have similarities to others in other systems or regions of the body.

Seeliger likened kinases to a control panel on a space shuttle. “Nothing about the sequence tells you about the role of the switches,” which would make it difficult for astronauts to know which switch to turn and in what order to bring the shuttle home.

Another question he’d like to address involves a greater understanding of the complexity of a living system. So far, he’s looked at properties of these kinases under controlled conditions. When he moves into a more complex environment, the inhibitors will likely interact and yield unexpected binding or connections.

Frohman appreciated Seeliger’s overall approach to his work and his contribution to the field. He cited the popularity of a review article Seeliger wrote that documents how drug molecules find their target binding site. Frohman said this work, which was published in the Journal of the American Chemical Society, was cited over 400 times in other articles.

Seeliger has been “very dedicated to moving this field forward. We were very excited about the topic and have been very pleased with the work he’s done on it since arriving at SBU,” Frohman said.

A resident of Stony Brook, Seeliger lives with his wife Jessica Seeliger, an assistant professor in the Department of Pharmacological Sciences who works on developing drugs for tuberculosis. The couple has two young children.

“We are all very happy they are both here as independent scientists,” Frohman added.

Indeed, Hannun called Jessica Seeliger an “outstanding and highly talented scientist,” as well.

Seeliger grew up in Hanover, Germany. He became interested in science in high school when he watched “The Double Helix,” which showed the development of the structural model of DNA.

His lab currently has two postdoctoral researchers and two doctoral candidates. Ultimately, Seeliger hopes his research helps establish an understanding of the way various kinases are functionally similar in how they interact with drugs.

“We wish we would be able to design more specific inhibitors without having to test dozens and dozens of compounds by trial and error,” he explained. He hopes to continue to build on his work with kinases, including exploring what happens when mutations in these switches cause disease.

by -
0 1855
Malagasy women break up granite stones to be used as gravel in the construction of the IUCN research center. Photo from Ali Yapicioglu

By Daniel Dunaief

After considerable planning, fundraising and coordinating, Patricia Wright welcomed a star-studded group of scientists, government officials and conservationists recently for the roof raising of the new IUCN Saving Our Species Biodiversity Research Center in Madagascar.

The building, which cost about $1 million, is a part of Centre ValBio, which is a conservation and research center Wright, a Distinguished Service Professor and award-winning researcher  at Stony Brook University, founded in 2003. CVB is near Ranomafana National Park in the southeastern part of the African island nation.

Above, a sketch of the IUCN Saving Our Species Biodiversity Research Center/Image courtesy of InSite Architecture

When it is completed this summer, the new building, which includes a green roof balcony and a central staircase and breezeway, is expected to provide research facilities for about ten scientists. They will study insects and plants, frogs and lemurs, the primates Wright has observed, researched, and shared with the public for over 30 years. Visiting scientists can apply to work at the center starting in September.

Russell Mittermeier, the Chief Conservation Officer at Global Wildlife Conservation and a research professor in the Department of Anatomical Sciences at Stony Brook, suggested that these types of efforts pay dividends.

It’s “hard to predict what will be found but history has shown us that there are endless benefits to conserving biodiversity and maintaining healthy ecosystems,” Mittermeier, the Chair of the IUCN/ SSC Primate Specialist Group, explained in an email from Madagascar.

Conservationists credit Wright with adding the new Biodiversity Centre to the larger research and conservation presence in Madagascar.“Wright was instrumental” in developing the facility, said Christoph Schwitzer, the Director of Conservation at Bristol Zoological Society and the Deputy Chair and Red List Authority Coordinator of the IUCN SSC Primate Specialist Group. “Without her, it wouldn’t be there. She started this whole project.”

The IUCN expressed its appreciation for the work Wright put in to continue to build on her track record of conservation.

At IUCN, “we highly value our collaboration with [Wright] and we understand she has established a good relationship with the Park Manager of Ranomafana National Park,” Remco Van Merm, the Coordinator of IUCN’s Saving Our Species initiative, explained in an email.

Save Our Species funds projects that “enhance the conservation of threatened species,” Van Merm added. “In the case of the new SOS Biodiversity Research Centre at Centre ValBio in Madagascar, the research that will be carried out will contribute greatly to the conservation of lemurs and other threatened biodiversity” in the national park.

Wright insisted that the new biodiversity center use local materials and workers, as she did with the construction of Namanabe Hall, its much larger sister building on the CVB campus.

Wright “wants to have the local villagers be involved in the process,” said Ali Yapicioglu, a partner at InSite, an architectural firm in Perry, New York who worked on both buildings. The sand is from the river, while the gravel comes from granite pieces that local women break down into smaller pieces.

In addition to local labor and materials, Wright ensured that InSite provided education to Malagasy residents, which included classes at the construction site. Through the building process, InSite also trained electricians.

While CVB, which is the largest biodiversity research center in the country, is well-established, it took considerable work on the Stony Brook scientist’s part to create it.

Schwitzer said Wright “fought against various forces trying to set this center up and she succeeded. She’s an excellent fundraiser.”

Madagascar has presented numerous challenges for conservation, in large part because of the changes in governments.Mittermeier recently had a “good discussion” with Andry Rajoelina about biodiversity just before Rajoelina was inaugurated as president of Madagascar last week. “Let’s see what he does” on biodiversity, Mittermeier explained. The Stony Brook professor plans to recommend that Rajoelina visit Ranomafana. 

For visitors, the CVB site offers ecotourists a firsthand opportunity to observe the charismatic lemur species, which are a part of the “Madagascar” animated films and were also the subject of an Imax movie about Wright’s work called “Island of Lemurs: Madagascar.”

“People who go there can see quite a few interesting lemur species in the wild,” Schwitzer said, adding that the station also gives Schwitzer “hope for lemur conservation,” he said.

The SOS lemur program originated with a 2013 published report, which included permanently managed field stations as a critical element. Research and field stations deter logging and lemur hunting, while also contributing scientific information that the government can use to set policies and make informed decisions, he added.

The lemur action plan includes the construction of this building. Schwitzer indicated that these types of initiatives, spread throughout the country, are critical to protecting species under various pressures, including habitat destruction.

“If we don’t keep up the effort, we could very well lose one,” Schwitzer said. He hastened to add that no lemurs have gone extinct in modern times, but “we can’t become complacent.” Indeed, the rarest of lemurs, the Northern Sportive Lemur, is down to 60 individuals in the world.

In the future, Schwtizer hopes Malagasy leaders and institutions will apply for international funding for themselves, as they drive the conservation goal forward.

This September, Wright will also finish an Education Center on the lower campus. On the upper campus, which is just across the road, she is building a wildlife center that will include a vet clinic, a frog breeding center, a mouse lemur facility, and a climate and drone center. The facility will also include bungalows for long-term researchers.

In addition to providing a field station for researchers, the site will also provide information accessible to the public.

“We are producing online identification systems like iNaturalist and also putting vocalizations and videos of the wildlife online,” Wright explained in an email.

Schwitzer said he has attended meetings where Wright has shared her vision for CVB with scientists and conservationists.

“Everybody looks at this and says, ‘This is cool. I want to do something like that,’” Schwitzer said.

by -
0 3988
From left, graduate students Prakhar Avasthi, Alisa Yurovsky, Charuta Pethe and Haochen Chen with director Steven Skiena, center. Photo by Gary Ghayrat/Stony Brook University

By Daniel Dunaief

Steven Skiena practices what he teaches. Named the director of the Institute for AI-Driven Discovery and Innovation in the College of Engineering and Applied Sciences at Stony Brook University, Skiena is using artificial intelligence to search for three staff members he hopes to hire in this new initiative.

He is looking for two tenured professors who will work in the Department of Computer Science and one who will be a part of the Department of Biomedical Informatics.

“We hope to use an artificial intelligence screen,” which Skiena calls a Poach-o-matic to “identify candidates we might not have thought of before. Ideally, the program will kick up a name and afterward, we’d bump our hand on our head and say, ‘Of course, this person might be great.’”

Steven Skiena. Photo from SBU

Artificial intelligence and machine learning have become popular areas in research institutions like Stony Brook, as well as in corporations with a wide range of potential applications, including in search engine companies like Google.

Skiena, who is a distinguished teaching professor, said he has “several candidates and we’re now actively interviewing,” adding that many departments on campus have faculty who are interested in applying machine learning in their work.

“There’s been an explosion of people from all disciplines who are interested in this,” Skiena said. He recently met with a materials scientist who uses machine learning techniques to improve experimental data. He’s also talked with people from the business school and from neuroscience.

SBU students have also shown considerable interest in these areas. Last semester, Skiena taught 250 graduate students in his introduction to data science class.

“This is a staggering demand from students that are very excited about this,” he said. Machine learning has become a “part of the standard tool kit for doing mathematical modeling and forecasting in many disciplines and that’s only going to increase.”

In an recent email, Andrew Schwartz, a core faculty at the institute and an assistant professor in the Department of Computer Science at Stony Brook, said he believes bringing in new faculty “should attract additional graduate students that may become future leaders in the field.”

Increasing coverage of AI beyond the current expertise in vision, visualization, natural language processing and biomedical engineering can “go a long way. There are a large amount of breakthroughs in AI that seemingly come from taking an idea from one subfield and applying it to another.” Schwartz appreciates the impact Skiena, who is his faculty mentor, has had on the field.

Skiena has “managed to contribute to a wide range of topics,” Schwartz explained. His book, “The Algorithm Design Manual,” is used by people worldwide preparing for technical interviews. Knowing this book thoroughly is often a “suggested step” for people preparing to interview at Google or other tech companies, Schwartz added.

The students in Schwartz and Skiena’s labs share space and have regular weekly coffee hours. Schwartz appreciates how Skiena often “presents a puzzling question or an out-of-the-box take on a question.”

The core technical expertise at the institute is in machine learning, data science, computer vision and natural language processing.

The creation of the institute shows that Stony Brook is “serious about being one of the top universities and research centers for expertise in AI,” explained Schwartz.

A few years ago, researchers realized that the artificial intelligence models developed biases based on the kind of training data used to create them. “If you’re trying to build a system to judge resumes to decide who will be a good person to hire for a certain type of job” the system has a danger of searching for male candidates if most or all of the people hired had been male in the past, Skiena explained.

Unintentional biases can creep in if the data sets are skewed toward one group, even if the programmer who created the artificial intelligence system was using available information and patterns.

In his own research, Skiena, who has been at Stony Brook since 1988, works on natural language processing. Specifically, he has explored the meaning of words and what a text is trying to communicate.

He has worked on sentiment analysis, trying to understand questions such as whether a particular political figure who receives considerable media coverage is having a good or bad week.

Another project explores the quality of news sources. “Can you algorithmically analyze large corpuses of news articles and determine which are reliable and which are less so?” he asked. 

One measure of the reliability of a news source is to determine how much other articles cite from it. “It is important to teach skepticism of a source” of news or of data, Skiena said. 

“When I teach data science, a lot of what I teach includes questions of why you believe a model will do a good thing and why is a data source relevant,” he added.

A resident of Setauket, Skiena lives with his wife Renee. Their daughter Bonnie is a first-year student at the University of Delaware, where she is studying computer science. Their tenth-grade daughter Abby attends Ward Melville High School and joins her father for bike rides on Long Island.

Skiena, who grew up in East Brunswick, New Jersey, said he appreciates the university community. By working in the AI field, Skiena, who has seven doctoral students in his lab, said he often observes glitches in online models like article classification on Google News or advertisements selected for him on a website to try to figure out why the model erred. He has also developed a sense of how probability and random events work, which he said helps him not overinterpret unusual events in day-to-day life.

As for his work at the institute, Skiena hopes Stony Brook will be recognized as a major player in the field of machine learning and areas of artificial intelligence. “We have good faculty in this area already and we’re hiring more. The hope is that you reach critical mass.”

by -
0 3664
Jason Sheltzer. Photo by ©Gina Motisi, 2018/CSHL

By Daniel Dunaief

A diagnosis of cancer brings uncertainty and anxiety, as a patient and his or her family confront a new reality. But not all cancers are the same and not all patients are the same, making it difficult to know the severity of the disease.

As doctors increasingly focus on individual patient care, researchers are looking to use a wealth of information available through new technology to assist with everything from determining cancer risks, to making early diagnoses, to providing treatment and aftercare.

Jason Sheltzer, a fellow at Cold Spring Harbor Laboratory, and his partner Joan Smith, a senior software engineer at Google, have sought to use the genetic fingerprints of cancer to determine the likely course of the disease.

By looking at genes from 20,000 cancer patients, Sheltzer and Smith found that a phenomenon called copy number variation, in which genes add copies of specific long or short sequences, is often a good indicator of the aggressiveness of the cancer. Those cancers that have higher copy number variation are also likely to be the most aggressive. They recently published their research in the journal eLife.

While the investigation, which involved work over the course of four years, is in a preliminary stage, this kind of prognostic biomarker could offer doctors and patients more information from which to make decisions about treatment. It could also provide a better understanding of the course of a disease, as copy number variation changes as cancer progresses.

“The main finding is simply that copy number variation is a much more potent prognostic biomarker than people had realized,” Sheltzer said. “It appears to be more informative than mutations in most single genes.”

Additionally, despite having data from those thousands of patients, Sheltzer and Smith don’t yet know if there’s a tipping point, beyond which a cancer reaches a critical threshold.

Some copy number changes also were more problematic than others. “Our analysis suggested that copy number alterations affecting a few key oncogenes and tumor suppressors seemed to be particularly bad news for patient prognosis,” Sheltzer said, adding that they weren’t able to do a clinical follow-up to determine how genes changed as the cancer progressed. 

“Hopefully, we can follow up this study, where we can do a longitudinal analysis,” he said.

Joan Smith. Photo by Seo-young Silvia Kim

Smith, who has written computer code for Twitter, Oracle and now Google, wrote code that’s specific to this project. “The analysis we’ve done here is new and is on a much more significant scale than the analysis we did in the past,” she said.

Within the paper, Smith was able to reuse parts of code that were necessary for different related experiments. Some of the reusable code cleaned up the data and provided a useful format, while some of the code searched for genetic patterns.

“There is considerable refinement that went into writing this code, and into writing code in general,” she explained in an email.

Smith has a full-time job at Google, where she has to clear any work she does with Sheltzer with the search engine. Before publication, she sent the paper to Google for approval. She works with Sheltzer “on her personal time,” and her efforts have “nothing to do with Google or Google Tools.”

The search engine company “tends to be supportive of employees doing interesting and valuable external work, as long as it doesn’t make use of any Google confidential information or Google owned resources,” including equipment supplies or facilities, she explained in an email.

The phenomenon of copy number variation occurs frequently in people in somatic cells, including those who aren’t battling a deadly disease Sheltzer said. “People in general harbor a lot of normal copy number variation,” he added.

Indeed, other types of repetitive changes in the genome have played a role in various conditions.

Some copy number variations, coupled with deletions, can be especially problematic. A tumor suppressor gene called P53, which is widely studied in research labs around the world, can accumulate copy number variations.

“Patients who have deletions in P53 tend to accumulate more copy number alterations than patients who don’t,” Sheltzer said. “A surprising result from our paper is that copy number variation goes above and beyond P53 mutations. You can control for P53 status and still find copy number variations that act as significant prognostic biomarkers.”

The copy number variations Sheltzer and Smith were examining were affecting whole genes, of about 10,000 bases or longer.

“We think that is because cancers are Darwinian,” explained Sheltzer. “The cells are competing against one another to grow the fastest and be the most aggressive. If a cancer amplifies one potent oncogene, it’s good for the cancer. If the cancer amplifies 200 others, it conveys a fitness penalty in the context of cancer.”

Smith is incredibly pleased to have the opportunity to contribute her informatics expertise to Sheltzer’s research, bringing together skill sets that are becoming increasingly important to link as technology makes it possible to accumulate a wealth of data in a much shorter term and at considerably lower expense.

Smith has a physics degree from MIT and has been in the technology world ever since.

“It’s been super wonderful and inspiring to get to do both” technology work and cancer research, she said.

The dynamic scientific duo live in Mineola. They chose the location because it’s equidistant between their two commutes, which are about 35 minutes. When they are not working, the couple, who have been together for eight years and have been collaborating in their research for almost all of them, enjoy biking, usually between 30 to 60 miles at a time.

Sheltzer greatly appreciates Smith’s expertise in using computer programs to mine through enormous amounts of data.

They are working on the next steps in exploring patient data.

by -
0 2301
Stony Brook’s iGem team pose with Randy Rettberg, president of the iGem Foundation, at the event. Photo from SBU

Stony Brook’s University’s 2018 team for the International Genetically Engineered Machine (iGEM) competition took home the university’s first gold medal during the four-day iGEM Giant Jamboree held at Hynes Convention Center in Boston in October. 

Since 2014, Stony Brook’s iGEM teams have competed at this annual event, previously receiving bronze and silver medals for their student-designed synthetic biology projects. This year’s competition involved 343 teams from around the world, including 60 from different colleges and universities in the U.S. Stony Brook was one of only seven collegiate teams from the U.S. to earn a gold medal.

Stony Brook’s iGem team pose with Randy Rettberg, president of the iGem Foundation, at the event. Photo from SBU

Led by sophomores Priya Aggarwal and Matthew Mullin, the 14-member team’s project, The Sucrose Factory, focused on the use of cyanobacteria to economically sink carbon dioxide by simultaneously producing sucrose that can be used to produce biofuels and bioplastics. Their project proposal was the only one to win all three open competitions offered by the iGEM sponsors Genscript, Opentrons and Promega. 

The iGEM competition promotes the advancement of synthetic biology through education and a competition aimed at developing an open and collaborative community of young scientists. Synthetic biology projects developed by previous SBU iGEM teams have ranged from a search for innovative treatments for diabetes and pancreatic cancer to lowering the cost of vaccine preservation. At Stony Brook, new teams are recruited each year, and members are mentored by students from previous teams and advised by Peter Gergen, director of undergraduate biology and a professor in the Department of Biochemistry and Cell Biology. 

“The Jamboree was a great experience for the 14 students on the team, and I think there may actually be some long-term potential in the ideas behind their project,” said Gergen, who said he is very proud of this interdisciplinary and talented group of students. 

In addition to Aggarwal, a human evolutionary biology major, and Mullin, a mechanical engineering major, members of Stony Brook’s 2018 iGEM team are Stephanie Budhan ’21, chemistry; Woody Chiang ’19, biochemistry and psychology double major; Dominika Kwasniak ’20, biochemistry; Karthik Ledalla ’21, biomedical engineering; Matthew Lee ’21, biology; Natalie Lo ’21, biology; Lin Yu Pan ’20, health science; Jennifer Rakhimov ’21, biology; Robert Ruzic ’19, biomedical engineering; Manvi Shah ’21, psychology; Lukas Velikov ’21, computer science; and Sarah Vincent ’19, biology.

More details on the team’s project are available at https://2018.igem.org/Team:Stony_Brook/Team.

by -
0 2045
Danny Bluestein and Wei-Che Chiu, a Stony Brook biomedical engineering doctoral student, with ventricular assist devices. Photo from SBU

By Daniel Dunaief

Some day, a doctor may save your life, repairing a calcified heart valve that jeopardizes your health. But then, the doctor may owe his or her latest lifesaving procedure to the work of people like Danny Bluestein, a professor in biomedical engineering and the director of the Biofluids Laboratory at Stony Brook University, and an international team of colleagues.

The group is working on restoring blood flow from the heart to the body using approaches for patients for whom open heart surgery is not an option.

Recently, the National Institutes of Health awarded the research crew a five-year $3.8 million grant to work on a broad project to understand ways to improve transcatheter aortic valve replacements, or TAVR, while reducing or minimizing complications from the procedure.

Danny Bluestein with his wife, Rita Goldstein. Photo from D. Bluestein

The grant is “not just about developing a new device, which we’ve been developing already for several years, but it’s also developing it in such a way that it answers challenges with disease and what clinical problems current technology offers solutions for,” Bluestein said.

TAVR provides a prosthetic valve for high-risk surgery patients. Like stents, TAVR is inserted through an artery, typically near the groin, and is delivered to the heart, where it improves the efficiency of an organ compromised by calcification on a valve and on the aorta itself.

Patients who have been candidates for TAVR are usually over 70 and often struggle to walk, as their hearts are enlarged and lose flexibility.

TAVR surgeries are performed in as many as 40 percent of such operations in some parts of Europe and the United States. The numbers have been increasing in the last couple of years as the technology has improved in different iterations of TAVR.

These valves are not only helping high-risk patients, but they are also assisting moderate and lower risk candidates.

Doctors have used TAVR for off-label uses, such as for people who have congenital difficulties with their valves, and for people who have already had open heart surgeries whose replacement valves are failing and who may be at risk for a second major heart operation.

Recovery from TAVR is far easier and less complicated than it is for cardiac surgery, typically requiring fewer days in the hospital.

Indeed, numerous researchers and cardiologists anticipate that this percentage could climb in the next several years, particularly if the risks continue to decline.

The team involved in this research effort is working with a polymer, hoping to reduce complications with TAVR and develop a way to tailor the valve for specific patients.

“If you’re a polymer person like me, you know we can make this work,” said Marvin Slepian, the director of the Arizona Center for Accelerated BioMedical Innovation at the University of Arizona. Slepian is pleased to continue a long collaboration with Bluestein, whose expertise in fluids creates a “unique approach to making something happen.”

The tandem is working with Rami Haj-Ali, the Nathan Cummings Chair in Mechanics in the Faculty of Engineering at Tel-Aviv University in Ramat Aviv, Israel. “To enable this technology, we need to better understand the current” conditions, said Haj-Ali, who uses computer methods to study the calcium deposited on the valve to understand the stages of the disease.

The valve Bluestein is proposing includes “new designs, new simulations, and new materials” that can create “less reactions with patients and overcome” problems TAVR patients sometimes face, Haj-Ali explained.

One of the significant challenges with TAVR is that it typically only lasts about five to six years.

“The idea of the NIH and this project is to extend the built-in efficiency of such a procedure,” Bluestein said. “TAVR is moving very fast to extend its functionality and durability.”

When the valve is inserted into the body, it is folded to allow it to fit through the circulatory system. This folding, however, can damage the valve, making it fail faster than in the surgical procedure.

As a part of this research, Bluestein and his team will explore ways to change the geometry of the TAVR according to the needs of the patient, which will enhance its functionality for longer. Bluestein and others will test these changing shapes through models constructed on high-performance computers, which can test the effect of blood flowing through shapes with specific physical passageways.

“Eventually, the future would involve custom designed valves, which would be optimal for the specific patient and will extend the lifespan of such a device,” Bluestein said.

A current off-label use of the TAVR valve involves assisting people born with an aortic valve that has two leaflets. Most aortic valves have a third leaflet. People with bicuspid aortic valves develop symptoms similar to those with calcification.

Going forward, Bluestein and his team plan to design valves that are specific for these patients.

A small percentage of patients with TAVR also require pacemakers. The device can interact with the electrophysiology of the heart and impair its rhythm because it creates pressure on the tissue. It is likely pushing against special nodes that generate the heart rhythm.

These studies include exploring the mechanical stress threshold that requires implantation of a pacemaker. By moving the device to a slightly different location, it may not interfere with the heart rhythm.

A resident of Melville and Manhattan, Bluestein is married to Rita Goldstein, who is a professor of psychiatry and neuroscience at the Icahn School of Medicine at Mount Sinai. 

Bluestein was raised in Israel, where he did his doctoral work. He became intrigued by the study of the flow of blood around and through the heart because he was interested in blood as a living tissue.

As for the ongoing work, Haj-Ali is optimistic about the group’s prospects. The scientists that are a part of this effort “bring something to the table that, in combination, doesn’t exist” elsewhere, he said.

by -
0 1850
Tim Sommerville. Photo by Brian Stallard, 2018/ CSHL

By Daniel Dunaief

Many research efforts search for clues about the signals or processes that turn healthy cells into something far worse. Scientists look at everything from different genes that are active to signs of inflammation to the presence of proteins that aren’t typically found in a system or organ.

Tim Somerville, a postdoctoral researcher in Chris Vakoc’s laboratory at Cold Spring Harbor Laboratory, recently took a close look at a specific protein whose presence in a high concentration in pancreatic cancer typically worsens the expectations for a disease with an already grim prognosis.

This protein, called P63, has a normal, healthy function in skin cells for embryos and in maintaining normal skin for adults, but it doesn’t perform any important tasks in the pancreas.

Tim Somerville at Cold Spring Harbor Laboratory. Photo by Brian Stallard, 2018/ CSHL

Somerville wanted to know whether the protein appeared as a side effect of the developing cancer, like the appearance of skinny jeans someone wears after a diet starts working, or whether it might be a contributing cause of the cancer’s growth and development.

“What was unclear was whether [the higher amount of P63] was a correlation, which emerges as the disease progresses, or something more causal,” he said, adding that he wanted to find out whether “P63 was driving the more aggressive features” of pancreatic cancer.

Somerville increased and decreased the concentration of P63 in tissue cells and organoids, which are copies of human tumors, hoping to see whether the change had any effect on the cancer cells.

The postdoctoral researcher knocked out the amount of P63 through the use of CRISPR, a gene-editing technique. He also overexpressed P63, which is also a transcription factor.

“From those complementary experiments, we were able to show that P63 is driving a lot of the aggressive features of cancer cells,” Somerville concluded. “Rather than being a correlation that’s observed, it is functionally driving the cancer itself.”

Somerville recently published his research in the journal Cell Reports.

As a transcription factor, P63 recognizes specific DNA sequences and binds to them. With P63, Somerville observed that it can bind to DNA and switch on many genes that are active in the worse form of pancreatic cancer. He and his collaborators describe P63 as a master regulator of the gene program.

Pancreatic cancer is often discovered after the irreversible conversion of normal, functional cells into a cancerous tumor that can spread to other organs. It also resists chemotherapy. Research teams in the labs of Vakoc and Dave Tuveson, the director of the Cancer Center at CSHL, and other principal investigators at CSHL and elsewhere are seeking to understand it better so they can develop more effective treatments.

Tim Somerville. Photo by Yali Xu

Vakoc was impressed with the work his postdoctoral researcher performed in his lab. Somerville is “one of the most scholarly young scientists I have ever met,” Vakoc explained in an email. “He is simply brilliant and thinks deeply about his project and is also driven to find cures for this deadly disease.”

At this point, Somerville is pursuing why P63 is activated in the pancreas. If he can figure out what triggers it in the first place, he might be able to interfere with that process in a targeted way. He also might be able to think about ways to slow it down or stop the disease.

The form of P63 that is active in the pancreas is not a mutated version of the protein that functions in the skin. If scientists tried to reduce P63, they would need to develop ways to suppress the cancer promoting functions of P63 without suppressing its normal function in the skin.

Many of the genes and proteins P63 activates are secreted factors and some of them contribute to inflammation. Indeed, researchers are exploring numerous ways inflammation might be exacerbating the progression of cancer.

P63 is also active in other types of cancer, including lung, head and neck cancers. Frequently, elevated levels of P63 in these other forms of cancer also lead to a worse prognosis.

Somerville explained that the changes P63 makes in a pancreatic cancer cell may expose new weaknesses. By studying cells in which he has overexpressed the protein, he hopes to see what other addictions the cells may have, which could include a reliance on other proteins that he could make compounds to target.

A resident of Huntington, Somerville has worked in Vakoc’s lab for three years. While he has spent considerable time studying P63, he is also looking at other transcription factors that are involved in pancreatic cancer.

Somerville wants to contribute to the discovery of why one form of pancreatic cancer is so much worse than the other. “If we can understand it, we can find new ways to stop it,” he said.

Originally from Manchester, England, Somerville is working in the United States on a five-year visa and plans to continue contributing to Vakoc’s lab for the next couple of years. At that point, he will consider his options, including a potential return to the United Kingdom.

Tim Somerville. Photo by Gina Motisi, 2018/CSHL

Somerville appreciates the opportunity to work on pancreatic cancer with Vakoc and with Tuveson, whose lab is next door. The researcher is enjoying his time on Long Island, where he takes walks, enjoys local restaurants and, until recently, had been playing on a Long Island soccer team, which played its matches in Glen Cove.

For Somerville, Cold Spring Harbor Laboratory has exceeded his high expectations. “The research that goes on here and the interactions you can have at meetings” have all contributed to a “great experience,” he said.

Somerville is excited to be a part of the pancreatic cancer team.

“With the work from [Tuveson’s] lab and ours, we’re finding new things we didn’t know,” he said. “It’s only when you understand those different things and the complexity that you can start thinking about how to tackle this in a more successful way. If the research carries on, we’ll make improvements in this disease.”

Prev1...505152...72Next Page 51 of 72
TBR News Media is your local news and entertainment website.
We provide you with the latest breaking news and information for your community.
Contact us: [email protected]

Most Viewed

©